James E. Dentzer's most recent trade in Imunon Inc was a trade of 4,405 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on Jan. 2, 2026.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Imunon Inc | James E. Dentzer | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jan 2026 | 4,405 | 4,405 | - | - | Stock Option (Right to Buy) | |
| Imunon Inc | James E. Dentzer | Director | Grant, award, or other acquisition of securities at price $ 9.20 per share. | 04 Aug 2025 | 3,318 | 3,318 (0%) | 0% | 9.2 | 30,526 | Common Stock |
| Imunon Inc | James E. Dentzer | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Aug 2025 | 250 | 250 | - | - | Stock Option (Right to Buy) | |
| Curis Inc | James E. Dentzer | Director, President & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 May 2025 | 360,000 | 360,000 | - | - | Employee stock option (right to buy) | |
| Imunon Inc | James E. Dentzer | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Mar 2025 | 3,750 | 3,750 | - | - | Stock Option (Right to Buy) | |
| Curis Inc | James E. Dentzer | Director, President & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Jan 2025 | 40,000 | 40,000 | - | - | Employee stock option (right to buy) | |
| Imunon Inc | James E. Dentzer | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Sep 2024 | 3,634 | 17,301 | - | - | Stock Option (Right to Buy) | |
| Imunon Inc | James E. Dentzer | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Jun 2024 | 4,500 | 13,667 | - | - | Stock Option (Right to Buy) | |
| Curis Inc | James E. Dentzer | Director, President & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 May 2024 | 100,000 | 100,000 | - | - | Employee stock option (right to buy) | |
| Imunon Inc | James E. Dentzer | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Mar 2024 | 4,500 | 9,167 | - | - | Stock Option (Right to Buy) | |
| Imunon Inc | James E. Dentzer | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Mar 2023 | 2,000 | 4,667 | - | - | Stock Option (Right to Buy) | |
| Curis Inc | James E. Dentzer | Director, President & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Jan 2023 | 1,000,000 | 1,000,000 | - | - | Employee stock option (right to buy) | |
| Curis Inc | James E. Dentzer | Director, President & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Jan 2022 | 825,000 | 825,000 | - | - | Employee stock option (right to buy) | |
| Curis Inc | James E. Dentzer | Director, President & CEO | Sale of securities on an exchange or to another person at price $ 3.07 per share. | 27 Jan 2022 | 3,094 | 64,877 (0%) | 0% | 3.1 | 9,499 | Common Stock |
| Curis Inc | James E. Dentzer | Director, President & CEO | Sale of securities on an exchange or to another person at price $ 3.18 per share. | 27 Jan 2022 | 2,406 | 67,971 (0%) | 0% | 3.2 | 7,651 | Common Stock |